DocDollars

Anika Therapeutics, Inc.

MA · United States · Reporting entity ID 100000010397

Total reported 2019–2025
$27.1M
#261 of 2,960 reporting companies — 0% of all reported industry payments
$24.3M in general payments across 6,395 records, plus $2.84M in research funding across 436 records.

How it breaks down

General payments $24,291,820
Research funding $2,837,848

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Anika Therapeutics, Inc. reported $27.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #261 of 2,960 reporting companies. 10% of that was research funding and 90% general payments such as consulting, speaking, food and travel. 6,395 general payment records and 436 research records were filed.

Common questions about Anika Therapeutics, Inc.

How much has Anika Therapeutics, Inc. paid US doctors?

Anika Therapeutics, Inc. reported $27,129,669 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $24,291,820 in general payments, $2,837,848 in research funding.

How does Anika Therapeutics, Inc. rank among drug and device companies?

It ranks #261 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Anika Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.